Back to Journals » OncoTargets and Therapy » Volume 8

Original Research

Heme oxygenase-1 is a predictive biomarker for therapeutic targeting of advanced clear cell renal cell carcinoma treated with sorafenib or sunitinib

       
Total article views   HTML views PDF downloads Totals
9,166 Dovepress* 8,560+ 1,295 9,855
PubMed Central* 606 290 896
Totals 9,166 1,585 10,751
*Since 10 August 2015
+Since July 2016

View citations on PubMed Central and Google Scholar